Articles related to 'metabolic profiling'
December 19, 2011 // Metabolomics
A New Perspective for the Future of Medicine Thanks to NMR Metabolomics
NMR has a great role to play in structural biology and in turn in systems biology. Its targets are proteins and nucleic acids. Small molecules in living beings, called metabolites, are an important chapter in systems biology and have always been markers of phenotypes and of health and disease. Metabolomics is the youngest of the omic sciences. It looks to define all metabolites in a specimen, i.e. a biological fluid, a tissue, a ... Continue reading
November 8, 2011 // Future Events
Hong Kong's First NMR Workshop, 12-14 December
Jointly organized and sponsored by Bruker BioSpin and the Department of Biology and Chemistry, at the City University of Hong Kong, the first NMR workshop will be held at the university from 12-14 December 2011. With a specific focus on current and growing applications in China, topics will range from basic to advanced NMR techniques, biological sample preparation, hyphenated techniques, quantitative NMR, assisted structure identification and much more. Applications will include solid state NMR, clinical applications, HR-MAS NMR, ... Continue reading
October 25, 2011 // Metabolomics
Imperial College, Real-Time Metabolic Profiling of Surgical Patients
Medical breakthroughs normally take a long time to reach a level where they are in common use, in fact 10 to 15 years is the norm. However, at the world’s first Centre for Surgical Metabonomics, a unique enterprise between Imperial College London and the Imperial College Healthcare NHS Trust, the focus is on translating new discoveries into new therapies as quickly as possible, namely the application of “molecular fingerprinting” technologies in a hospital setting to significantly improve surgical and therapeutic procedures. ... Continue reading
July 12, 2011 // Clinical Research
NMR-based urine screening delivers the most comprehensive overview of newborn health
An extremely promising project in NMR analysis is helping deliver efficient, reliable screening of inborn errors in newborn health. It has the potential to generate a push-button, high throughput screening solution offering simultaneous non-targeted and targeted analysis. Bruker’s participation in projects in Germany (Greifswald University Hospitals) and Turkey (12 hospitals coordinated by Infai GmbH) is helping to establish the screening method. Newborn health status in terms of growth, maturity, common disease recognition, and relativity to parameters not ... Continue reading
February 15, 2011 // Clinical Research
Optimizing Cancer Diagnosis and Treatment with Metabolic Profiling
To help realize the vision of enhancing patient diagnostics and treatment, the Norwegian University of Science and Technology in Trondheim (NTNU) has partnered with Bruker, the world's leading provider of NMR spectroscopy instrumentation. NTNU and Bruker have signed a research collaboration agreement to jointly develop, optimize and implement NMR cancer diagnostics and prognostic modelling. One of the goals for the NTNU-Bruker collaboration is to develop products that will progress MR high-throughput screening towards a routine clinical setting. ... Continue reading
